Trillium Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch TRIL and buy or sell other stocks, options, and ETFs commission-free!

About TRIL

Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation. 

CEO
Jan Skvarka, PhD, MBA
CEOJan Skvarka, PhD, MBA
Employees
Employees
Headquarters
Mississauga, Ontario
HeadquartersMississauga, Ontario
Founded
2004
Founded2004
Employees
Employees

TRIL Key Statistics

Market cap
1.94B
Market cap1.94B
Price-Earnings ratio
74.87
Price-Earnings ratio74.87
Dividend yield
Dividend yield
Average volume
3.67M
Average volume3.67M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$20.96
52 Week high$20.96
52 Week low
$5.80
52 Week low$5.80

TRIL Earnings

-$0.90
-$0.10
$0.69
$1.49
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, Pre-Market
ActualExpected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.